These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 33326851

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS, Abdulahad WH, Rutgers A, Horst G, Bijzet J, Arends S, Roffel MP, Boots AM, Brouwer E.
    Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
    Liozon E, de Boysson H, Dalmay F, Gondran G, Bezanahary H, Fauchais AL, Ly KH.
    J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
    De Miguel E, Karalilova R, Macchioni P, Ponte C, Conticini E, Cowley S, Tomelleri A, Monti S, Monjo I, Batalov Z, Klinowski G, Falsetti P, Kane DJ, Campochiaro C, Hočevar A.
    Ann Rheum Dis; 2024 Feb 15; 83(3):335-341. PubMed ID: 37932008
    [Abstract] [Full Text] [Related]

  • 33. Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases.
    Pujades-Rodriguez M, Duyx B, Thomas SL, Stogiannis D, Smeeth L, Hemingway H.
    Heart; 2016 Mar 15; 102(5):383-9. PubMed ID: 26786818
    [Abstract] [Full Text] [Related]

  • 34. Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica.
    Reitsema RD, Hesselink BC, Abdulahad WH, van der Geest KSM, Brouwer E, Heeringa P, van Sleen Y.
    Front Immunol; 2023 Mar 15; 14():1201575. PubMed ID: 37600779
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.
    Sharma A, Mohammad AJ, Turesson C.
    Semin Arthritis Rheum; 2020 Oct 15; 50(5):1040-1048. PubMed ID: 32911281
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
    Crowson CS, Matteson EL.
    Semin Arthritis Rheum; 2017 Oct 15; 47(2):253-256. PubMed ID: 28551169
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study.
    Kobayashi D, Suyama Y, Osugi Y, Arioka H, Takahashi O, Kuriyama N.
    Int J Rheum Dis; 2018 Jun 15; 21(6):1314-1321. PubMed ID: 29879315
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.